Patent · US Active

Brain tissue damage therapies

US7923007B2 · kind B2 · utility

1Cited by

0References

13Claims

0Family size

Assignee

ACADEMIA SINICA · TW

Inventors

Hung Li · Taipei, TW
Woei-Cherng Shyu · Taipei, TW
Dah-Ching Ding · Fengchuan, TW
Shin-Zong Lin · Hualien City, TW

Key dates

Filing date	Aug 4, 2006
Grant date	Apr 12, 2011
Priority date	—
Expiry date	Jul 31, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K35/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A cultured pluripotent animal cell that is CD13+, CD90+, and CD117−. Also disclosed are methods for making the cell and methods of treating a brain tissue damage and increasing the expression level of a neuraltrophic factor in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.